The temporal gene expression landscape of rhabdomyolysis-induced acute kidney injury reveals the timing of complement activation

Rhabdomyolysis-induced acute kidney injury (RIAKI) involves complement activation, but its role as a therapeutic target remains unclear. We analyze urine and kidney biopsies from RIAKI patients and use a glycerol-induced mouse model to investigate complement activation and its contribution to RIAKI. Here we show that complement fragments Ba, Bb, C5a, and sC5b-9 are elevated in the urine of patients with RIAKI, and C3 staining is detected in injured tubules, often surrounded by C5aR1-expressing myeloid cells. However, pharmacologic C5 or C5aR1 inhibition fail to prevent RIAKI in mice. A kinetic analysis reveal that complement activation occurs later in the disease course, following early tubular injury and immune cell infiltration. Initial cytoprotective responses are rapidly overwhelmed, leading to tubular damage and chemokine-driven C5aR1-expressing myeloid cells recruitment. These findings suggest that complement cascade is not an initiating factor in RIAKI and underscore the multifactorial nature of this disease.

Authors

Institutions

Publication Details

Journal
Communications Biology
Published
2025-12-31
DOI
https://doi.org/10.1038/s42003-025-09449-y
Primary Topic
Complement system in diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The temporal gene expression landscape of rhabdomyolysis-induced acute kidney injury reveals the timing of complement activation

T. Woodruff, Marie Frimat, S. Gaudry, Idris Boudhabhay et al.
Communications Biology
Complement system in diseases
article

The temporal gene expression landscape of rhabdomyolysis-induced acute kidney injury reveals the timing of complement activation

T. Woodruff, Marie Frimat, S. Gaudry, Idris Boudhabhay, Victoria Poillerat, Anne Grünenwald, Gilles Crambert, Mohamad Khairul Amir Zaidan, H. Nielly, Margot Revel, Julie Oniszczuk, Laurent Gilardin, Amine Majdi, Khalil Chaïbi, M. Aletti, Julien Guihaire, Elodie Voilin, Lubka Roumenina, Viviane Gnemmi
article en

Abstract

Rhabdomyolysis-induced acute kidney injury (RIAKI) involves complement activation, but its role as a therapeutic target remains unclear. We analyze urine and kidney biopsies from RIAKI patients and use a glycerol-induced mouse model to investigate complement activation and its contribution to RIAKI. Here we show that complement fragments Ba, Bb, C5a, and sC5b-9 are elevated in the urine of patients with RIAKI, and C3 staining is detected in injured tubules, often surrounded by C5aR1-expressing myeloid cells. However, pharmacologic C5 or C5aR1 inhibition fail to prevent RIAKI in mice. A kinetic analysis reveal that complement activation occurs later in the disease course, following early tubular injury and immune cell infiltration. Initial cytoprotective responses are rapidly overwhelmed, leading to tubular damage and chemokine-driven C5aR1-expressing myeloid cells recruitment. These findings suggest that complement cascade is not an initiating factor in RIAKI and underscore the multifactorial nature of this disease.

Communications BiologyVol. 9(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), The University of Queensland (AU), Université Paris Cité (FR), Université de Lille (FR), Université Paris-Saclay (FR), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Université Sorbonne Paris Nord (FR), Sorbonne Paris Cité (FR), Centre de Recherche des Cordeliers (FR), Assistance Publique – Hôpitaux de Paris (FR), Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine (FR), Centre Hospitalier Intercommunal de Poissy (FR), Metabolism and Renal Physiology (FR), Hôpital Avicenne (FR), Hôpital d'Instruction des Armées Bégin (FR), Hôpital Paris Saint-Joseph (FR), Hôpital d'instruction des Armées Percy (FR), Hôpital Jean-Verdier (FR), Hôpital Foch (FR), Bicêtre Hospital (FR), Hôpital Tenon (FR), CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers (FR), Maladies rénales fréquentes et rares : des mécanismes moléculaires à la médecine personnalisée
European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Sorbonne Université, Université de Paris
Good health and well-being
Openalex Percentile: Top 35%
Complement system in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.